Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV

20 Nov 2020

Abstract excerpt

The beginning of 2020 brought us information about the novel coronavirus emerging in China. Rapid research resulted in the characterization of the pathogen, which appeared to be a member of the SARS-like cluster, commonly seen in bats. Despite the global and local efforts, the virus escaped the health care measures and rapidly spread in China and later globally, officially causing a pandemic and global crisis in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Thermal Regulation in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33219167
DOI: 10.1128/jvi.01622-20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoVPMID 33219167Read ↗

Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19.Semantic proximity Read ↗

Bioactive natural compounds against human coronaviruses: a review and perspectiveSemantic proximity Read ↗

Identification of Broad Anti-Coronavirus Chemical Agents for Repurposing Against SARS-CoV-2 and Variants of ConcernSemantic proximity Read ↗

Promising natural products against <scp>SARS‐CoV</scp>‐2: Structure, function, and clinical trialsSemantic proximity Read ↗

A Novel Chemical Compound for Inhibition of SARS Coronavirus HelicaseSemantic proximity Read ↗

Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronavirusesSemantic proximity Read ↗

Homo-harringtonine (HHT) – A highly effective drug against coronaviruses and the potential for large-scale clinical applicationsSemantic proximity Read ↗

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus-M <sup>Pro</sup> inhibitors with potent in vivo efficacySemantic proximity Read ↗

Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A Medicinal Chemistry approach.Semantic proximity Read ↗

Anthracyclines inhibit SARS-CoV-2 infectionSemantic proximity Read ↗

Thiazolidinones: Potential Human Novel Coronavirus (SARS-CoV-2) Protease Inhibitors Against COVID-19Semantic proximity Read ↗

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M Pro inhibitors with potent in vivo efficacySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.